Loading organizations...
Loading organizations...
Develops drugs for treating soil-transmitted helminthiasis.
Zero Point Five Therapeutics has raised $7.2M across 1 funding round.
Zero Point Five Therapeutics has raised $7.2M in total across 1 funding round.
Zero Point Five Therapeutics has raised $7.2M in total across 1 funding round.
Zero Point Five Therapeutics's investors include Trish Costello.
Zero Point Five Therapeutics has raised $7.2M across 1 funding round. Most recently, it raised $7.2M Series A in July 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 17, 2023 | $7.2M Series A | Trish Costello |